USSTOCK.TODAY
Weekend. Closed
Log in Sign up

MediWound Records $3.6 Million in Q3 Revenue and Focuses on Clinical Pipeline

The Motley Fool +1 · ·by G4L

MDWD
MDWD MediWound Ltd
$12.90 -0.54%
View chart & analysis →
  1. 1MediWound revenue for Q3 2026 was $3.6 million.
  2. 2MediWound R&D expenses for Q3 2026 were $6.2 million.
  3. 3The U.S. Department of War provided $3.3 million in additional non-dilutive funding to MediWound.

So what's the key point?

MediWound generated $3.6 million in revenue during the third quarter. Additional funding from the U.S. Department of War allows the company to focus on research.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

MediWound Records $6 million Loss in Third Quarter Associated Press · yesterdayMediWound to Proceed with EscharEx Phase 3 Clinical Trials and Comparison with Madrigal Pharmaceuticals Case FinanceWire · Nov 3Virgin Galactic (SPCE) reports $55.9 million loss in Q2 Associated Press +2 · Aug 13
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news